Triple therapy with rituximab, intravenous immunoglobulin, and intravitreal corticosteroids for melanoma-associated retinopathy: ttriic does the trick
Conclusion:
This is the first reported case of the utility of triple therapy with rituximab, intravenous immunoglobulin, and intravitreal steroids for successful management of melanoma-associated retinopathy as demonstrated by improvement in acuity, symptoms, visual fields, and electroretinography.
Source: Retinal Cases and Brief Reports - Category: Opthalmology Tags: Case Report Source Type: research
More News: Corticosteroid Therapy | Eyes | Melanoma | Opthalmology | Rituxan | Skin Cancer | Vitamin A